Craneware PLC
LSE:CRW

Watchlist Manager
Craneware PLC Logo
Craneware PLC
LSE:CRW
Watchlist
Price: 1 965 GBX 2.61% Market Closed
Market Cap: 697.8m GBX
Section:
 

Relative Value

The Relative Value of one CRW stock under the Base Case scenario is 2 207.26 GBX. Compared to the current market price of 1 965 GBX, Craneware PLC is Undervalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CRW Relative Value
Base Case
2 207.26 GBX
Undervaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.6
P/S
P/S
Price to Sales
4.6
vs History
63
vs Industry
28
Median 3Y
4.7
Median 5Y
5.1
Industry
2.4
Forward
0
More Details
47.6
P/E
P/E
Price to Earnings
47.6
vs History
88
vs Industry
6
Median 3Y
70
Median 5Y
72.6
Industry
22.9
Forward
0.2
More Details
15.6
P/OCF
P/OCF
Price to OCF
15.6
vs History
68
vs Industry
19
Median 3Y
15.4
Median 5Y
21.8
Industry
14.7
More Details
27.8
P/FCFE
P/FCFE
Price to FCFE
27.8
vs History
49
vs Industry
21
Median 3Y
27
Median 5Y
27.3
Industry
21.4
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
52
vs Industry
33
Median 3Y
2.8
Median 5Y
2.8
Industry
2.3
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
40
Median 3Y
0.1
Median 5Y
-0.5
Industry
2.6
Forward
-0.2
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
57
Median 3Y
0.2
Median 5Y
-0.6
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
34
Median 3Y
0.5
Median 5Y
-1.8
Industry
12.3
Forward
-0.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
18
Median 3Y
1.4
Median 5Y
-5
Industry
17.2
Forward
-0.8
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
32
Median 3Y
0.2
Median 5Y
-0.8
Industry
15
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
22
Median 3Y
0.3
Median 5Y
-1
Industry
19
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
57
Median 3Y
0.1
Median 5Y
-0.2
Industry
1.9
More Details

Multiples Across Competitors

CRW Competitors Multiples
Craneware PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Craneware PLC
LSE:CRW
695.8m GBP 4.6 47.6 -70.4 -157.3
US
Veeva Systems Inc
NYSE:VEEV
37.6B USD 12.2 43.6 33.3 34.8
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
21.9B AUD 99.6 190.6 131.3 131.3
JP
M3 Inc
TSE:2413
1.5T JPY 4.4 31.7 16.1 19.8
US
Doximity Inc
NYSE:DOCS
8B USD 12.9 31.8 27.7 29
US
Waystar Holding Corp
NASDAQ:WAY
5.4B USD 5.2 48.7 16.3 25.6
SE
Sectra AB
STO:SECT B
45.3B SEK 20.3 70.1 -138.4 -138.4
CN
Winning Health Technology Group Co Ltd
SZSE:300253
30.9B CNY 14.3 -100.4 -198.4 -198.4
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
291.2B INR 10.9 59.9 37.3 43.5
US
Inspire Medical Systems Inc
NYSE:INSP
2.8B USD 3.2 63.2 50.5 67.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Craneware PLC
LSE:CRW
Average EV/EBITDA: 41.8
Negative Multiple: -70.4
12%
N/A
US
Veeva Systems Inc
NYSE:VEEV
33.3
39%
0.9
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
131.3
32%
4.1
JP
M3 Inc
TSE:2413
16.1
14%
1.2
US
Doximity Inc
NYSE:DOCS
27.7
23%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
16.3
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -138.4 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -198.4
36%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.3
24%
1.6
US
Inspire Medical Systems Inc
NYSE:INSP
50.5
85%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Craneware PLC
LSE:CRW
Average EV/EBIT: 49.4
Negative Multiple: -157.3
36%
N/A
US
Veeva Systems Inc
NYSE:VEEV
34.8
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
131.3
31%
4.2
JP
M3 Inc
TSE:2413
19.8
N/A N/A
US
Doximity Inc
NYSE:DOCS
29
25%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
25.6
58%
0.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -138.4 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -198.4
47%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43.5
26%
1.7
US
Inspire Medical Systems Inc
NYSE:INSP
67.9
34%
2

See Also

Summary
CRW intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRW stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRW stock valuation using valuation multiples.
Wall Street Estimates
CRW price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRW stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.